Clinical Trial Update: Persistence of Hepatitis B Antibody Levels & Immune Response to a Hepatitis B Vaccine Challenge [Phase 4]

View source ↗

Summary

Phase 4 study evaluating how long Hepatitis B antibodies persist and the immune response after a Hepatitis B vaccine challenge; study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Engerix-B (hepatitis B vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 4 | Status: COMPLETED